BMY250117C82500
- 0.01
- 0.000.00%
Bristol-Myers Squibb Newsroom
Jefferies Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $70
Jefferies Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $70
Bernstein Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $62
Bernstein Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)
Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $52 From $53, Maintains Neutral Rating
Bristol-Myers Squibb Analyst Ratings
Truist Securities Maintains Buy on Bristol-Myers Squibb, Raises Price Target to $65
Truist Financial Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Announces Target Price $65
Jefferies Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $70
Jefferies Reaffirms Their Buy Rating on Bristol-Myers Squibb (BMY)
Bernstein Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $62
Bernstein Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY)
J.P. Morgan Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Raises Target Price to $70
Bristol-Myers Squibb Analyst Ratings
Jefferies Upgrades Bristol-Myers Squibb(BMY.US) to Buy Rating, Raises Target Price to $70
Jefferies Upgrades Bristol-Myers Squibb to Buy From Hold, Adjusts Price Target to $70 From $63
Berenberg Bank Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $60
Berenberg Bank Remains a Hold on Bristol-Myers Squibb (BMY)
B of A Securities Reinstates Neutral on Bristol-Myers Squibb, Announces $63 Price Target
Bristol-Myers Squibb Analyst Ratings